Covid-19 roundup: US in­ves­ti­gat­ing more my­ocardi­tis cas­es linked to Mod­er­na vac­cine; UK ap­proves Re­gen­eron mAb

The Wash­ing­ton Post re­port­ed late last night that CDC and FDA of­fi­cials are in­ves­ti­gat­ing where there might be a high­er risk of my­ocardi­tis, a type of heart con­di­tion, in younger adults than pre­vi­ous­ly be­lieved for those re­ceiv­ing the Mod­er­na Covid-19 vac­cine.

While the two Post sources stressed that the side ef­fect still prob­a­bly re­mains un­com­mon, the FDA and CDC are look­ing in­to Cana­di­an da­ta that sug­gest the Mod­er­na vac­cine may car­ry a high­er risk for young peo­ple, par­tic­u­lar­ly males un­der 30, than the Pfiz­er-BioN­Tech vac­cine. They’re al­so tak­ing an­oth­er look at the US da­ta.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER